Summary: An evaluation of enzyme immunoassays for determination of thyroxine in serum (EMIT ABA thyroxine assay, Syva Corp., ENZYMUN assay thyroxine, Boehringer Mannheim) and of thyroxine binding index (ENZYMUN assay TBI 1 ), Boehringer Mannheim) is presented. The precision of the enzyme immunoassays was adequate (coefficients of variation ranged from day to day with EMIT from 3-11% and with ENZYMUN from 4-11%). Both assays are specific and easy to perform. About 20 unknown samples can be analyzed in duplicate by EMIT within 60 minutes and by ENZYMUN within 250 minutes. A comparison of the results obtained by enzyme immunoassays and radioimmunoassay in a series of about 100 patients showed a good correlation between both methods. The precision of the ENZYMUN TBI assay was adequate (coefficient of variation from day to day 4.9%) and the thyroxine/TBI-ratio correlated well with the thyroxine/TBG-ratio. 
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Materials and Methods
Materials
The reagents for the EMIT ABA thyroxine assay were provided by E. Merck (D-6100 Darmstadt). Reagents for the ENZYMUN assays, thyroxine and TBI were from Boehringer Mannheim (D-8132 Tutzing). Kits for the determination of thyroxinebinding globulin (RIA-GNOST, TBG) were purchased from Behring-Werke (D-3550 Marburg). Triiodothyronine, Triiodothyroacetic acid and tetraiodothyroacetic acid were a generous gift from Henning (D-1000 Berlin). Z,-thyroxine was purchased from Sigma (D-8021 Taufkirchen).
Enzyme immunoassays
Thyroxine was assayed by the EMIT ABA thyroxine assay designed for use with the ABA 100 Bichromatic Analyzer (Abbott, D-6070 Langen) equipped with an auxiliary dispenser.
Determinations of thyroxine and TBI by ENZYMUN assays were carried out with an Eppendorf system 5090 (Eppendorf, D-2000 Hamburg 63) at a wavelength of 405 nm.
All of these enzyme immunoassays (EMIT, ENZYMUN) were performed according to the manufacturer's instructions. Unknown samples were analyzed by EMIT in duplicate and by ENZYMUN in triplicate, as recommended by the manufacturers.
Radio immunoassays
Thyroxine determinations by radioimmunoassay were carried out with a double antibody technique, which is used as the present routine procedure.
20 μΐ of serum or thyroxine standard (A), 400 μ\ of barbital buffer containing [ 125 IJL-thyroxine (B), 200 μ\ of antiserum against thyroxine (C) and 100 μ\ of precipitating antiserum (D) are incubated for 18 hours at room temperature. The samples are then centrifuged for 15 minutes at 2400 g and the supernatant is discarded. The pellet is washed once with 1 ml of bidistilled water. The antibody-bound radioactivity is measured using gamma counters (Berthold, D-7547 Wildbad; Packard, D-6000 Frankfurt/M.). All samples were analyzed in duplicate. Standard curves were calculated by "spline function" (11) using a Diehl Alphatronic calculator (Diehl, D-8500 N rnberg).
Reagents
(A) Thyroxine-free serum was prepared according to Meinhold & Wenzel (12) . Charcoal (200 g, Norit A, Serva, D-6900 Heidelberg) was added to pool serum (11) , stirred overnight at 4°C and then centrifuged for 8 hours at 20 000 g. The supernatant was filtered using quartz wool and then spiked with £-thyroxine (Henning, D-1000 Berlin) (19- (C) Thyroxine-bovine-serum-albumin-conjugate was prepared according to Oliver (13) and Hesch (14) by coupling /,-thyroxine-ethylester-hydrochloride (Henning, D-1000 Berlin) to bovine serum albumin (Behring, D-3550 Marburg) using l-ethyl-3(3-dimethylaminopropyl)-carbodiimidehydrochlpride (Serva, D-6900 Heidelberg). Two mg of thyroxine-bovine-serunv ' albumin-conjugate dissolved in 1 ml complete Freund's adjuvant and 9 g/1 sodium chloride solution (volumes 0.5 ml + 0.5 ml) were subcutaneously injected at various places on the back of rabbits every 14 days. The reaction medium of the assay contains thyroxine antiserum in a final dilution of 1:5400 (affinity constant 2.5 X 10 10 l/mol).
(D) As precipitating antiserum anti-rabbit ^-globulin .from donkey (Wellcome, D-3006 Gro burgwedel) was used (final dilution in the reaction medium 1:144). Thyroxine-binding globulin (TBG) was determined by use of the RIA-GNOST TBG assay according to the instructions of the manufacturer.
Calculation of FTI and T 4 /TBG-ratio FTI was calculated as thyroxine G*g/dl)/TBI, and T 4 /TBG-ratio as thyroxine (Mg/dl) X 10 O O/TBG (mg/1).
Reference ranges
Reference ranges for thyroxine, TBG, FTI and T 4 /TBG-ratio were used as indicated by the manufacturers of the various kits.
With our radioimmunoassay for determination of thyroxine the reference range used was 51.5-167.3 nmol/1. This reference range was established by the analysis of 150 samples from clinically euthyroid patients (age: 20-65 years). As the results showed a normal distribution the reference range was calculated from the mean value and two standard deviations.
Furthermore, the various reference ranges were examined for their validity for the patient collective tested in this study. It was found that the median of the results obtained with this collective was in each case in the middle of the corresponding reference range. Therefore the use of the mentioned reference ranges appeared to be justified.
Thyroxine values given in Mg/dl are converted into nmol/1 by multiplication with 12.87.
Results
Precision
With various commercial control sera the coefficients of variation ranged from day to day with EMIT from 3-5%, with ENZYMUN from 4-7% and with the radioimmunoassay from 6-8% (tab. 1). At low thyroxine concentrations (25-30 nmol/1) coefficients of variation of about 11% were found with the enzyme immunoassays. These precision data refer to duplicate determinations.
Accuracy
Average recoveries of thyroxine added to pooled thyroxine-free human serum are shown in table 2. At various thyroxine concentrations between 64 and 260 nmol/1 the recovery with EMIT was 94-100%, with the ENZYMUN assay 96-103%, and with the radioimmunoassay 97-107%.
Furthermore the results measured by ENZYMUN thyfoxine assay and radioimmunoassay in 107 specimens from patients were compared. The leastsquares regression analysis ( fig. 1 ) showed the slope of the line to be 0.97. The value of the intercept was 2.7 nmol/1. The correlation between the results was good (r = 0.972). The mean values obtained by ENZYMUN and radioimmunoassay were 121.2 ± 56.5 nmol/1 and 122,0 ± 56.5 nmol/1 respectively. A significant difference between the results of both methods was not present (t-value 0.59). Reproducible deviations of more than 30% between the results of both assays occurred in 2 out of 107 cases. Only one of these discrepancies was clinically relevant: a hypothyroid patient was erroneously classified euthyroid by the ENZYMUN assay.
Tab. 1. The precision from day to day of the ENZYMUN-, EMIT ABA assay and radioimmunoassay for determination of thyroxine in serum. Assays were performed in duplicate on various days as indicated and the mean values were used for calculation of the precision. r = 0.935. The mean value of the results determined by EMIT (y = 114.1 ± 45.2 nmol/1) was 3.7% lower than that found with radioimmunoassay (x = 118.5 ± 52.7 nmol/1). The t-value was 2.34 (p < 0.0125).
ENZYMUN
Reproducible differences of more than 30% between the results of both methods occurred in 4 out of 102 cases. Only two of these discrepances were clinically relevant: one hypo-and one hyperthyroid patient were falsely classified euthyroid by the EMIT assay.
The correlation between these enzyme immunoassays and the radioimmunoassay was satisfactory, also when the samples contained elevated concentrations of thyroxine-binding globulin ( fig. 1, 2 ).
Specificity
The specificity of the enzyme-and radioimmunoassays for the determination of thyroxine was tested by the determination of the cross-reactivity with structurally related compounds. The results obtained with spiked thyroxine-free human serum samples are shown in table 3. For each drug the concentration was determined at which it exerts an absorbance or counts per minute equivalent to 25.7 nmol/1 thyroxine in the corresponding enzyme-or radioimmunoassay. Triiodpthyronine and the two thyroxine metabolites triiodothyroacetic acid and tetraiodothyroacetic acid (15) showed a distinctly stronger cross-reaction iii the EMIT assay than in the ENZYMUN-and radioimmunoassay. As the reference range of these compounds, however, is very low, a relevant interference is usually not to be expected in any of these tests.
Interferences
Hemoglobin concentrations up to 1.0 g/1 showed no interference in both enzyme immunoassays.
The influence of lipemia on these tests was studied with lipemic sera (n = 15; triglyceride concentration: x: 11.0 mmol/1, range 3.4-19.8 mmol/1), which were assayed undiluted and after dilution (1:2) with 9 g/1 sodium chloride solution. Results of diluted samples were multiplied with the dilution factor. No interference was found with the ENZYMUN assay (thyroxine (nmol/1): x: 86.2; diluted samples, x: 87.5).
With the EMIT assay lower thyroxine concentrations were measured in undiluted samples (x: 68.2 nmol/1; diluted samples: x: 81.1 nmol/1).
In icteric sera higher thyroxine concentrations were found by the enzyme immunoassays than by radioimmunoassay. In about 50% of the determinations the results of the enzyme immunoassays showed a reproducible deviation of more than 30% from those of the radioimmunoassay. However a clear-cut relationship between these discrepancies and the bilirubin concentration could not be detected ( fig. 3,4) . If serum samples were spiked with bilirubin, no interference was found with the radio-and enzyme immunoassays at bilirubin concentrations up to 600 jumol/l. So far it cannot be concluded whether bilirubin or another yet unidentified agent which might be present in icteric sera, was responsible for the discrepancies observed. Moreover, it is not clear whether the interference present was in the radio-or in the enzyme immunoassays. Further investigations of this phenomenon are in progress. Determination of free thyroxine index by ENZYMUN TBI assay An enzyme immunoassay for the determination of the thyroxine binding index (TBI), based on the ENZYMUN thyroxine assay, has been developed (10), and it is commercially available. This test can be used like triiodothyronine (T 3 ) uptake tests for an indirect estimate of the protein binding of thyroid hormones. T 3 uptake tests have proved clinically useful and have been combined with measurement of total thyroxine (16) to yield free thyroxine index (FTI; calculated as T 4 /T 3 uptake or TBI), which has been found to correlate with both the clinical state of patients and the free T 4 concentration as measured directly (17) . Recently however it was demonstrated that the T 4 /thyroxine-binding globulin (TBG) ratio provides a better index of thyroid function than does FTI (18, 19) . Therefore we compared the FTI determined by the ENZYMUN assay with the T 4 /TBG ratio. The correlation between both ratios was good. The serum samples tested contained concentrations of thy roxine-bin ding globulin between 16 and 48 mg/1 ( fig. 5 ). In the presence of elevated TBG concentrations (> 30 mg/1) the regression line appears to have a higher slope than in the presence of TBG concentrations in the normal range. Discrepancies concerning the classification of patients into eu-, hypo-or hyperthyroid occurred in 6 out of 77 cases. In 5 of these cases the T 4 /TBG ratio was slightly below the normal range, whereas the T 4 /TBI ratio was normal. Three of these patients were clinically euthyroid. A relevant discrepancy was present in only one case, which was classified euuiyroid by T 4 /TBG ratio and hyper^t hyroid by FTI. The clinical state of this patient was hyperthyroid. It has to be considered however, that the reference ranges used are preliminary and still the subject of investigation. The precision of the ENZYMUN TBI assay was acceptable. From day to day a coefficient of variation of 4.9% was obtained (x = 1.0; n = 20; mean values of duplicate determinations).
Discussion
Both enzyme immunoassays (EMIT, ENZYMUN) for determination of thyroxine were precise and accurate. As the precision of the ENZYMUN and EMIT assay was satisfactory the performance of the duplicate determinations of unknown samples appears to be adequate.
The results of the enzyme immunoassays correlated well with those obtained by a radioimmunoassay. With few exceptions, the subsequent clinical interpretation was identical for all three methods used.
The linear regression analysis of the results obtained by EMIT and radioimmunoassay points to a proportional error of about 20% and to a constant error of 18.9 nrriol/1 (20) . The results of the EMIT assay tended to be higher at thyroxine concentrations below 90 nmol/1 and lower at concentrations above this value than the results determined by radioimmunoassay.
Similar regression constants were found when the EMIT assay was performed with an "Autochemist" analyzer (21), a Kem-O-Mat analyzer (22) or, as in our study, with an ABA 100 analyzer (23) .
Accordingly, the recovery at thyroxine concentrations above 129 nmol/1 was only about 95% (tab. 2) and at lower concentrations (38.6 nmol/1) 107% (23) . As the Syva Corp. recommends an upper limit of the euthyroid range which is about 10% lower and a lower limit which is about 10% higher than that used with the radioimmunoassay, these deviations had no relevant influence on the clinical interpretation of the results.
Both enzyme immunoassays are easy to perform. 20 unknown duplicate samples can be analyzed by the EMIT ABA assay within 60 minutes and by the. ENZYMUN assay within 250 minutes.
The ENZYMUN TBI assay seems to be suitable for an indirect estimate of the protein binding of thyroid hormones. A T 3 -uptake test based on the EMIT technique has also been described (24) . The direct measurement of TBG has the advantage that it is better standardized than indirect methods, and it is independent of the endogenous thyroid hormone concentration. Therefore the direct determination of TBG is preferred by various authors (25, 26) .
In summary it is concluded from our results that the enzyme immunoassays tested (EMIT, ENZYMUN) can be used as well as radioiminunoassay for the determination of thyroxine and TBI in serum. If only in-vitro procedures are considered, the determination of an index of free thyroxine is reportedly sufficient for primary thyroid diagnostic and therapy control in about 60-70% of all cases of an unselected patient collective (27) . Thus a relatively large proportion of in vitro thyroid diagnostic may be reliably conducted by the enzyme immunoassays tested in this study.
